Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 230,936 shares at $28.68 ($6.6M) on 2025-12-09, disclosed to the SEC on 2025-12-11.
Open-market sale of $6.6M TEVA by Executive VP, European Commercial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.68 | 115,468 | $3.3M | 50.0% |
| 2 | $28.68 | 115,468 | $3.3M | 50.0% |
| Total | $28.68 avg | 230,936 | $6.6M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-03-07 | $2.3M | — | Filing → |